Demonstrates a scoring system for recurrence risk in trigeminal neuralgia, suggesting enhanced postoperative care.
The standard surgical treatment for medically refractory trigeminal neuralgia is microvascular decompression (MVD); however, despite positive immediate results, pain recurrence is still a concern. Individualized risk assessment and follow-up planning are not well supported by traditional binary outcome reporting. In order to stratify recurrence risk following MVD, we have developed a straightforward clinical framework called the Microvascular Decompression Predictive Management Score (MVD-PMS), which incorporates easily accessible clinical, imaging, operative, and early postoperative variables. To direct postoperative surveillance, counselling, and consideration of adjunctive interventions, patients are divided into three risk categories: low, intermediate, and high. MVD-PMS may enable personalized postoperative care and enhance long-term outcome evaluation by converting established prognostic factors into a useful scoring system.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: